Enke Bashllari, Ph.D., is the Founder and Managing Director of Arkitekt Ventures, an early-stage venture firm dedicated to advancing human health since January 2017. In addition, Enke serves as a Board Observer for Nanite, a biotech company focused on polymer nanoparticles for gene delivery, and participates as an investor and advisor for Parsley Health, a holistic chronic care management practice. Enke has also taken on roles such as Limited Partner at First Close Partners, Investor for CertifyOS, Sollis Health, Handspring Health, and Cofertility, and previously exited as an investor in HumanFirst through its acquisition by ICON Plc. Enke's academic background consists of an MBA from Harvard Business School, a Ph.D. from Columbia University Vagelos College of Physicians and Surgeons, and a BS in Biology-Chemistry from Lock Haven University of Pennsylvania.